Conrad et al. constructed a recombinant tanapox virus armed with FliC (from Salmonella enterica) that exhibited excellent oncolytic activity in colorectal cancer models in comparison with other recombinant strains expressing GM-CSF or CCL2 [33]. This evidence concerns the gene CCL2 and colorectal cancer.